Indication

Central Serous Chorioretinopathy

4 clinical trials

5 products

Clinical trial
Choroidal Blood Flow in Acute and Chronic Central Serous Chorioretinopathy
Status: Recruiting, Estimated PCD: 2025-12-31
Product
Placebo
Clinical trial
APEC-0016
Status: Withdrawn, Estimated PCD: 2006-04-01
Clinical trial
Sildenafil for Treatment of Choroidal Ischemia
Status: Active (not recruiting), Estimated PCD: 2024-12-01
Product
Sildenafil